Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamidronate for pain in sternocostoclavicular hyperostosis
NL-OMON27475Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in sternocostoclavicular hyperostosis (SCCH) comparing Pamidronate with Placebo (2 arms). Primary endpoint: Change in maximal pain score. Started Dec 2020; status: recruiting.
02
Drugs
pamidronate
03
Conditions
sternocostoclavicular hyperostosis (SCCH)
Beyond the preview
Go deeper on NL-OMON27475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27475.